Best Seller Of White Powders Nifurzide CAS NO (39978-42-2) In Bulk

Nifurzide (39978-42-2)

1. Chemical Identity: Nifurzide is a chemical compound with the molecular formula C12H9N3O5 and the CAS number 39978-42-2. It belongs to the class of nitrofuran derivatives and is characterized by its fused furan ring system with nitro and hydrazide functional groups.

2. Synthesis: Nifurzide is synthesized through the reaction of a furan compound with nitric acid and hydrazine under controlled conditions. This synthetic route allows for the introduction of both the nitro and hydrazide groups onto the furan ring, yielding the final product, nifurzide.

3. Pharmacological Activity: Nifurzide exhibits antibacterial activity, particularly against Gram-negative bacteria. It functions by interfering with bacterial nucleic acid synthesis, ultimately leading to cell death. This mechanism of action contributes to its efficacy in treating various bacterial infections.

4. Therapeutic Uses: Nifurzide is primarily used in the treatment of gastrointestinal infections caused by susceptible bacteria. It is effective against enteric pathogens such as Escherichia coli, Salmonella species, and Shigella species, making it a valuable therapeutic agent for treating diarrhea and enteritis.

5. Administration: Nifurzide is commonly administered orally in the form of tablets or capsules. The dosage and duration of treatment may vary depending on the severity of the infection, the patient's age and weight, and the specific bacterial strain causing the illness.

6. Safety Profile: Nifurzide is generally well-tolerated, with adverse effects being relatively uncommon. However, like other antibacterial agents, it may cause gastrointestinal disturbances such as nausea, vomiting, or diarrhea in some individuals. Allergic reactions are rare but can occur in sensitive individuals.

7. Resistance and Sensitivity: Prolonged or indiscriminate use of nifurzide can contribute to the development of bacterial resistance. Therefore, it is essential to use this medication judiciously and according to prescribed guidelines to minimize the risk of resistance emergence and preserve its effectiveness.

8. Pediatric and Special Populations: Nifurzide is suitable for use in pediatric patients, although dosing adjustments may be necessary based on the child's age and weight. Special caution is warranted in pregnant and breastfeeding women, and the medication should be used only if the potential benefits outweigh the risks.

9. Regulatory Approval and Availability: Nifurzide may be available under different brand names in various countries, and its availability may vary depending on local regulatory approvals and marketing authorizations. It is typically obtained through prescription from a qualified healthcare professional.

10. Future Perspectives: Continued research on nifurzide and its derivatives may focus on optimizing its pharmacokinetic properties, improving its spectrum of activity, and minimizing potential adverse effects. Additionally, efforts to combat bacterial resistance and ensure appropriate antibiotic stewardship are crucial for preserving the efficacy of nifurzide and other antibacterial agents in clinical practice.